AroCell
AroCell signs distribution agreement in Ethiopia
AroCell continues to expand its sales and distribution network in Africa. Today, AroCell has signed a distribution agreement with Sub-Saharan Biomedical P.L.C. covering the sale of TUBEX® TF in Ethiopia.
Since launching in Africa, AroCell has focused on finding the right partners for distribution. The company has previously announced that agreements have been signed with distributors in Uganda, Ghana, and Kenya among others. AroCell has now signed a new distribution agreement with Sub-Saharan Biomedical P.L.C. for distribution in Ethiopia. The agreement covers the sale of the company's rapid test TUBEX® TF for typhoid fever.
"We look forward to collaborating with Sub-Saharan Biomedical PLC for the distribution and marketing of TUBEX® TF. Ethiopia is a large country with 120 million inhabitants and a potentially important market. We are continuously working on expanding into new markets and this is part of AroCell's strategy on the African continent”, states Gunnar Wahlberg, Business Unit Director for Rapid tests at AroCell.
| Datum | 2023-02-01, kl 09:30 |
| Källa | MFN |
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.